US30050B1017
© PR Newswire
02.01.2026
EVH
LISTED
NYSE
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08
News Preview
WASHINGTON, Jan. 2, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, announced that the Compensation Committee of Evolent's Board of Directors approve...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
EVH
LISTED
NYSE
Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden
News Preview
WASHINGTON, Nov. 6, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, and American Oncology Network (AON), one of the nation's fastest-growing community oncology networks, today announced a new model enabling high-quali...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
EVH
LISTED
NYSE
Evolent Announces Third Quarter 2025 Results
News Preview
Q3 2025 financial results ahead of expectations.
Announces more than $500 million in newly-contracted annualized revenue to launch in 2026.
Expands leadership team to support accelerating growth.
WASHINGTON, Nov. 6, 2025 /PRNe...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
09.10.2025
EVH
LISTED
NYSE
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025
News Preview
Company to Participate in Upcoming Conferences
WASHINGTON, Oct. 9, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its third quarter...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
23.09.2025
EVH
LISTED
NYSE
Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners
News Preview
Transaction enhances focus on specialty condition management and accelerates Evolent's deleveraging path.Proceeds from the transaction to be used to prepay senior term debt; Immediately accretive to Evolent's free cash flow by more than $7 million per year.Evolent reiterates outlook for Q3 2025 and full year 2025 for Revenue and Adjusted EBITDA,...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
EVH
LISTED
NYSE
Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
News Preview
WASHINGTON, Aug. 19, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced the pricing of $145.0 million aggregate principal amount of 4.50% convertible senior notes due 2031. The notes are being offered only to persons reasonabl...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
EVH
LISTED
NYSE
Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
News Preview
WASHINGTON, Aug. 18, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced that it intends to offer $140.0 million aggregate principal amount of convertible senior notes due 2031, subject to market and other conditions. Evolent a...
Themefolio
Profiler
Peergroup
© PR Newswire
07.08.2025
EVH
LISTED
NYSE
Evolent Announces Second Quarter 2025 Results
News Preview
WASHINGTON, Aug. 7, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended June 30, 2025.
Seth...
Themefolio
Profiler
Peergroup
© PR Newswire
14.07.2025
EVH
LISTED
NYSE
Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
News Preview
Company to Participate in Upcoming Conferences
WASHINGTON, July 14, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its second quarter 2025 financial results on Thursday, August 7, 2025, after market close, with a confe...
Themefolio
Profiler
Peergroup
© PR Newswire
09.07.2025
EVH
LISTED
NYSE
Evolent announces key appointments to leadership team
News Preview
Dr. David Lim joins Evolent as chief clinical officerJohn Way joins Evolent as CFO, Performance SuiteWASHINGTON, July 9, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced leadership additions to its clinical and financial teams, as it co...
Themefolio
Profiler
Peergroup
© PR Newswire
20.06.2025
EVH
LISTED
NYSE
Evolent reiterates Q2 and full year guidance for Adjusted EBITDA
News Preview
Notes accelerating 2026 revenue bookings forecast
Secures incremental non-dilutive financing
WASHINGTON, June 20, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced that based on leading indicators and paid claims data through May, it con...
Themefolio
Profiler
Peergroup
© PR Newswire
08.05.2025
EVH
LISTED
NYSE
Evolent Announces First Quarter 2025 Results
News Preview
WASHINGTON, May 8, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended March 31, 2025.
Seth...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
22.04.2025
EVH
LISTED
NYSE
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors
News Preview
Former CFO of CVS Health, Aetna and Coventry Health Care brings deep experience driving growth and profitability.Mr. Guertin's nomination represents continuation of Evolent's board refreshment efforts.WASHINGTON, April 22, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for...
Themefolio
Profiler
Peergroup
© PR Newswire
15.04.2025
EVH
LISTED
NYSE
Evolent program achieves 20% reduction in use of low-value oncology regimens
News Preview
Program aims to achieve the best possible treatment outcomes — longer lives with fewer side-effects — without excess financial strain. Collegial provider engagement model brings together education, technology and incentives to encourage top-quality regimens. One low-value regimen costs about 70 times more than a clinically equivalent alternative....
Themefolio
Profiler
Peergroup
© PR Newswire
10.04.2025
EVH
LISTED
NYSE
Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025
News Preview
Company to Participate in Upcoming Conferences
WASHINGTON, April 10, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after market close, with a conferen...
Themefolio
Profiler
Peergroup
© PR Newswire
11.03.2025
EVH
LISTED
NYSE
Define Ventures Appoints Carolyn Magill as Venture Partner
News Preview
The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors
SAN FRANCISCO, March 11, 2025 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Carolyn Magill, former CEO of Aetion, has j...
Themefolio
Profiler
Peergroup
© PR Newswire
20.02.2025
EVH
LISTED
NYSE
Evolent Announces Fourth Quarter and Full Year 2024 Results
News Preview
Revenue of $646.5 million for the three months ended December 31, 2024 and $2,554.7 million for the year ended December 31, 2024, representing 16.3% and 30.1% growth over 2023, respectively.Net loss attributable to common shareholders of Evolent Health, Inc. of $30.6 million for three months ended December 31, 2024 and $93.5 million for the year...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2025
EVH
LISTED
NYSE
Evolent Health Announces Changes to Board of Directors
News Preview
Richard "Rick" Jelinek to Be Named Chair of the Board at 2025 Annual Meeting
Company Continues Board Refreshment Efforts with Brendan Springstubb's Appointment as New Independent Director
WASHINGTON, Feb. 4, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with co...
Themefolio
Profiler
Peergroup
© PR Newswire
27.01.2025
EVH
LISTED
NYSE
Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025
News Preview
Company to Participate in Upcoming Conferences
WASHINGTON, Jan. 27, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its fourth quarter 2024 financial results on Thursday, February 20, 2025, after market close, with a co...
Themefolio
Profiler
Peergroup
© PR Newswire
18.12.2024
EVH
LISTED
NYSE
Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1
News Preview
Longtime CMO Dr. Andrew Hertler to serve as senior advisor and CMO emeritus.
WASHINGTON, Dec. 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, announced the appointment of Dr. Von Nguyen as Chief Medical Officer, effective January 1, 2025.
Dr. Nguy...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2024
EVH
LISTED
NYSE
Humana and Evolent Expand Partnership to Enhance Oncology Care
News Preview
Humana Inc. (NYSE: HUM) and Evolent Health, Inc. (NYSE: EVH) announced they have expanded their strategic medical oncology partnership to modernize and streamline prior authorization processes to include radiation and surgical oncology services. By connecting all primary approaches to treating cancer, this collaboration will help expedite approval...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2024
EVH
LISTED
NYSE
Evolent Announces Third Quarter 2024 Results
News Preview
Revenue of $621.4 million, an increase of $110.4 million or 21.6%, from the three months ended September 30, 2023.Net loss attributable to common shareholders of Evolent Health, Inc. of $(31.2) million and a net loss margin of (5.0)%.Adjusted EBITDA of $31.8 million resulting in an Adjusted EBITDA margin of 5.1%.Revises outlook for Adjusted EBITD...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2024
EVH
LISTED
NYSE
Define Ventures Appoints Bruce Broussard as Venture Partner
News Preview
The former Fortune 50 CEO joins Define to further drive transformational change in healthcare at the earliest stages of innovation
SAN FRANCISCO, Oct. 22, 2024 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Bruce Broussard, former CEO and president of Hu...
Themefolio
Profiler
Peergroup
© PR Newswire
11.10.2024
EVH
LISTED
NYSE
Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024
News Preview
Company to Participate in Upcoming Conferences
WASHINGTON, Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its third quarter 2024 financ...
Themefolio
Profiler
Peergroup
© PR Newswire
08.08.2024
EVH
LISTED
NYSE
Evolent Announces Second Quarter 2024 Results
News Preview
Revenue of $647.1 million, an increase of $178.0 million or 37.9%, from the three months ended June 30, 2023.Net loss attributable to common shareholders of Evolent Health, Inc. of $(6.4) million and a net loss margin of (1.0)%.Adjusted EBITDA of $52.0 million resulting in an Adjusted EBITDA margin of 8.0%.Narrows revenue outlook for full year 20...
Themefolio
Profiler
Peergroup
© PR Newswire
11.07.2024
EVH
LISTED
NYSE
Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024
News Preview
Company to Participate in Upcoming Conferences
WASHINGTON, July 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its second quarter 2024 finan...
Themefolio
Profiler
Peergroup
© PR Newswire
04.06.2024
EVH
LISTED
NYSE
Evolent signs agreement to acquire artificial intelligence utilization management products and team from Machinify
News Preview
Machinify solution seeks to accelerate the efficiency, quality, and clinical value of Evolent's specialty condition management platform through AI-enabled clinical workflow automationMachinify technology leverages the latest advances in applied machine learning, large language models and data analyticsAcquisition expected to benefit health plans,...
Themefolio
Profiler
Peergroup
© PR Newswire
09.05.2024
EVH
LISTED
NYSE
Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.
News Preview
Digital cancer care platform Careology and Evolent (NYSE: EVH) to offer an innovative platform to enable cancer navigationEvolent will embed Careology's digital cancer care technology within its comprehensive care navigation services offered to health plan clients across the U.S.WASHINGTON, May 9, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE:...
Themefolio
Profiler
Peergroup
© PR Newswire
09.05.2024
EVH
LISTED
NYSE
Evolent Announces First Quarter 2024 Results
News Preview
Revenue of $639.7 million, an increase of $212.0 million or 49.6%, from the three months ended March 31, 2023.Net loss attributable to common shareholders of Evolent Health, Inc. of $(25.2) million and a net loss margin of (3.9)%.Adjusted EBITDA of $54.1 million resulting in an Adjusted EBITDA margin of 8.5%.Raises revenue outlook for full year 2...
Themefolio
Profiler
Peergroup
© PR Newswire
18.04.2024
EVH
LISTED
NYSE
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
News Preview
Company to Participate in Upcoming Conferences
WASHINGTON, April 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make healthcare simpler and more affordable, today announced it will release its first quarter 2024 financ...
Themefolio
Profiler
Peergroup
© PR Newswire
22.02.2024
EVH
LISTED
NYSE
Evolent Announces Fourth Quarter and Full Year 2023 Results
News Preview
WASHINGTON, Feb. 22, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months and year ended December 31, 2023.
Seth Blackley, Chie...
Themefolio
Profiler
Peergroup
© PR Newswire
14.02.2024
EVH
LISTED
NYSE
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors
News Preview
WASHINGTON, Feb. 14, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today appointed Russell Glass to its Board of Directors. Glass has almost 25 years of experience as a succes...
Themefolio
Profiler
Peergroup
© PR Newswire
25.01.2024
EVH
LISTED
NYSE
Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024
News Preview
Company to Participate in Upcoming Investor Conferences
WASHINGTON, Jan. 25, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its fourth quarter...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
